NuCana (NCNA) Consolidated Net Income (2017 - 2025)

NuCana (NCNA) reported Consolidated Net Income of -$3.7 million for Q4 2025, down 209.57% on a YoY basis from $3.4 million in Q4 2024, and down 181.11% sequentially from -$1.3 million in Q3 2025.

NuCana (NCNA) Consolidated Net Income (2017 - 2025) Analysis & Trends

NuCana (NCNA) has 9 years of Consolidated Net Income data on file, last reported at -$3.7 million in Q4 2025.

  • For the quarter ending Q4 2025, Consolidated Net Income fell 209.57% year-over-year to -$3.7 million; the trailing twelve-month figure through Dec 2025 stood at -$42.0 million (down 27.4% YoY), and the FY2025 full-year result was -$41.8 million, down 26.18% from the prior year.
  • Consolidated Net Income slipped to -$3.7 million in Q4 2025, from -$1.3 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of -$1.2 million in Q4 2024 to a low of -$33.0 million in Q2 2025.
  • A 5-year average of -$12.6 million and a median of -$12.0 million in 2023 frame the typical range for Consolidated Net Income.
  • Across the five-year window, Consolidated Net Income surged 90.68% in 2024 and tumbled 209.57% in 2025, its largest moves.
  • Tracing NCNA's Consolidated Net Income over 5 years: stood at -$24.0 million in 2021, then advanced by 8.42% to -$22.0 million in 2022, then surged by 41.86% to -$12.8 million in 2023, then surged by 90.68% to -$1.2 million in 2024, then plunged by 209.57% to -$3.7 million in 2025.
  • Business Quant data shows NCNA's Consolidated Net Income at -$3.7 million in Q4 2025, -$1.3 million in Q3 2025, and -$33.0 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -37.09 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 227.36 Mn
4 NuCana 279.75 Bn 279.75 Bn - -3.68 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 727.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -26.94 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 362.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -453.82 Mn
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn 205.99 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -3.68 Mn
Sep 30, 2025 -1.31 Mn
Jun 30, 2025 -33.04 Mn
Mar 31, 2025 -4.00 Mn
Dec 31, 2024 -1.19 Mn
Sep 30, 2024 -7.78 Mn
Jun 30, 2024 -12.04 Mn
Mar 31, 2024 -11.98 Mn
Dec 31, 2023 -12.77 Mn
Sep 30, 2023 -12.04 Mn
Jun 30, 2023 -8.49 Mn
Mar 31, 2023 -11.98 Mn
Dec 31, 2022 -21.96 Mn
Sep 30, 2022 -8.74 Mn
Jun 30, 2022 -7.91 Mn
Mar 31, 2022 -16.73 Mn
Dec 31, 2021 -23.98 Mn
Sep 30, 2021 -16.35 Mn
Jun 30, 2021 -17.13 Mn
Mar 31, 2021 -18.15 Mn